Literature DB >> 24986515

Telomere shortening is associated with genetic anticipation in Chinese Von Hippel-Lindau disease families.

Xiang-Hui Ning1, Ning Zhang2, Teng Li1, Peng-Jie Wu1, Xi Wang1, Xue-Ying Li3, Shuang-He Peng1, Jiang-Yi Wang1, Jin-Chao Chen1, Kan Gong4.   

Abstract

Von Hippel-Lindau (VHL) disease is a rare autosomal dominant cancer syndrome. A phenomenon known as genetic anticipation has been documented in some hereditary cancer syndromes, where it was proved to relate to telomere shortening. Because studies of this phenomenon in VHL disease have been relatively scarce, we investigated anticipation in 18 Chinese VHL disease families. We recruited 34 parent-child patient pairs (57 patients) from 18 families with VHL disease. Onset age was defined as the age when any symptom or sign of VHL disease first appeared. Anticipation of onset age was analyzed by paired t test and the other two special tests (HV and RY2). Relative telomere length of peripheral leukocytes was measured in 29 patients and 325 healthy controls. Onset age was younger in child than in parent in 31 of the 34 parent-child pairs. Patients in the first generation had older onset age with longer age-adjusted relative telomere length, and those in the next generation had younger onset age with shorter age-adjusted relative telomere length (P < 0.001) in the 10 parent-child pairs from eight families with VHL disease. In addition, relative telomere length was shorter in the 29 patients with VHL disease than in the normal controls (P = 0.003). The anticipation may relate to the shortening of telomere length in patients with VHL in successive generations. These findings indicate that anticipation is present in families with VHL disease and may be helpful for genetic counseling for families with VHL disease families and for further understanding the pathogenesis of VHL disease. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 24986515     DOI: 10.1158/0008-5472.CAN-14-0024

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma/paraganglioma.

Authors:  Nilesh Lomte; Sanjeet Kumar; Vijaya Sarathi; Reshma Pandit; Manjunath Goroshi; Swati Jadhav; Anurag R Lila; Tushar Bandgar; Nalini S Shah
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

2.  Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.

Authors:  Rodrigo Santa Cruz Guindalini; Andrew Song; James D Fackenthal; Olufunmilayo I Olopade; Dezheng Huo
Journal:  Cancer       Date:  2016-03-15       Impact factor: 6.860

Review 3.  Von Hippel-Lindau disease.

Authors:  Prashant Chittiboina; Russell R Lonser
Journal:  Handb Clin Neurol       Date:  2015

4.  Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.

Authors:  Jee-Soo Lee; Ji-Hyun Lee; Kyu Eun Lee; Jung Hee Kim; Joon Mo Hong; Eun Kyung Ra; Soo Hyun Seo; Seung Jun Lee; Man Jin Kim; Sung Sup Park; Moon-Woo Seong
Journal:  BMC Med Genet       Date:  2016-07-20       Impact factor: 2.103

5.  Genetic anticipation in Swedish Lynch syndrome families.

Authors:  Jenny von Salomé; Philip S Boonstra; Masoud Karimi; Gustav Silander; Marie Stenmark-Askmalm; Samuel Gebre-Medhin; Christos Aravidis; Mef Nilbert; Annika Lindblom; Kristina Lagerstedt-Robinson
Journal:  PLoS Genet       Date:  2017-10-31       Impact factor: 5.917

6.  Falcine meningioma in Von Hippel-Lindau disease: An unusual association.

Authors:  Domenico Murrone; Bruno Romanelli; Nicola Montemurro; Domenico Chirchiglia; Aldo Ierardi
Journal:  Surg Neurol Int       Date:  2018-02-14

7.  Shorter telomere length increases age-related tumor risks in von Hippel-Lindau disease patients.

Authors:  Jiang-Yi Wang; Shuang-He Peng; Xiang-Hui Ning; Teng Li; Sheng-Jie Liu; Jia-Yuan Liu; Bao-An Hong; Nie-Nie Qi; Xiang Peng; Bo-Wen Zhou; Jiu-Feng Zhang; Lin Cai; Kan Gong
Journal:  Cancer Med       Date:  2017-08-04       Impact factor: 4.452

8.  Intra-Familial Phenotypic Heterogeneity and Telomere Abnormality in von Hippel- Lindau Disease: Implications for Personalized Surveillance Plan and Pathogenesis of VHL-Associated Tumors.

Authors:  Jiangyi Wang; Xiang Peng; Cen Chen; Xianghui Ning; Shuanghe Peng; Teng Li; Shengjie Liu; Baoan Hong; Jingcheng Zhou; Kaifang Ma; Lin Cai; Kan Gong
Journal:  Front Genet       Date:  2019-04-24       Impact factor: 4.599

9.  Hemangioblastoma Instead of Renal Cell Carcinoma Plays a Major Role in the Unfavorable Overall Survival of Von Hippel-Lindau Disease Patients.

Authors:  Bowen Zhou; Jiangyi Wang; Shengjie Liu; Xiang Peng; Baoan Hong; Jingcheng Zhou; Kaifang Ma; Jiufeng Zhang; Lin Cai; Kan Gong
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

Review 10.  Telomere length as a potential biomarker of coronary artery disease.

Authors:  Joyeeta Bhattacharyya; Keichiro Mihara; Deborshi Bhattacharjee; Manjarí Mukherjee
Journal:  Indian J Med Res       Date:  2017-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.